Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110872260B details a Pd-catalyzed asymmetric hydrogenation route for chiral lactams, offering high ee and yield for pharmaceutical intermediates.
Novel patent CN105622699A offers precious metal-free route for steroidal intermediates, ensuring cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel patent CN115677771A offers efficient fosfomycin intermediate production with reduced costs and high purity for reliable pharmaceutical supply chains.
Patent CN114085219A details a high-ee synthesis of (1S,6R)-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4.3.0]nonane. This route offers superior yield and purity for reliable pharmaceutical intermediate supply chains.
Patent CN1634896A introduces a fixed-bed continuous method for piperazine synthesis, offering high selectivity and lower pressure operation for cost-effective pharmaceutical intermediate manufacturing.
Patent CN106046095B reveals mild Obeticholic acid synthesis. Eliminates LDA cryogenic steps. Enables cost reduction in pharmaceutical intermediates manufacturing.
Patent CN102675321B reveals a high-yield Ticagrelor synthesis route offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN102863335A reveals a green one-step synthesis for succinic acid diesters using CO2. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Novel Ru-BINAP method for L-Phenylephrine HCl reduces costs and improves purity for pharmaceutical supply chains.
Patent CN112645854B details a novel purification method for Apremilast intermediates using PEG-modified catalysts and specific solvent systems to achieve over 99.5% purity.
Advanced manufacturing of L-Phenylephrine HCl using optimized Rh-catalysis for high purity and cost-effective supply chain solutions.
Novel catalytic route for posaconazole reduces impurities and cost. Reliable supply chain partner for high-purity antifungal API manufacturing.
Novel asymmetric hydrogenation route for Apremilast intermediate offering significant cost reduction and supply reliability for pharmaceutical manufacturing partners seeking high-purity intermediates globally.
Novel patent CN109438540A enables cost-effective steroid synthesis. Reliable supply chain for high-purity pharmaceutical intermediates with scalable production.
Novel synthesis of 4'-hydroxy-4,6'-dimethoxydihydrochalcone via Pd/C hydrogenation offers high purity and scalable pharmaceutical intermediate production.
Patent CN111484424B reveals a copper-catalyzed route for omacycline intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN104327073B details a safer semi-synthetic route for Vinpocetine, eliminating column chromatography to ensure high purity and cost reduction in API manufacturing.
Patent CN113149911A details a green hydrogenation route for 5-aminobenzimidazole ketone. Achieve high purity and yield with reduced environmental impact for scalable supply.
Patent CN108069882A reveals continuous catalytic hydrogenation for anthranilic acid. Enhances purity and supply chain reliability for dye manufacturers significantly.
Patent CN112608279A details a novel synthesis for twisted benzimidazole diamines, enhancing optical properties and solubility for advanced polymer applications.